Beginning March 12, 2015, NOVA Chemicals Corporation (the “Company”) will no longer make its financial statements available to the general public. However, (1) holders of notes of the Company, (2) bona fide prospective investors who are either qualified institutional buyers or are non-US persons, (3) securities analysts, or (4) market makers in Company notes, can access Company information through the Company’s password-protected online data system. If you are included in any one of the above categories and wish to view Company information, please contact Carolyn Rose per the contact information provided below. Prior to providing log-in details, Ms. Rose may require proof that you fall within one of the above categories and are entitled to access to the data site.
Senior Corporate Paralegal
Pursuant to the Arrangement, a wholly-owned subsidiary of IPIC acquired all of
NOVA Chemicals issued and outstanding common shares for US $6.00 per share
on July 6, 2009.
Any questions and requests for assistance in surrendering certificates representing shares of NOVA Chemicals in order to receive consideration for such shares may be directed to the office of the depositary:
CIBC Mellon Trust Company
c/o Canadian Stock Transfer Company Inc.
320 Bay Street, Basement Level (B1)
Toronto, Ontario, M5H 4A6;
telephone: 1-800-387-0825 (Canada/US) or
(416) 682-3860 (outside Canada/US)
Non-registered shareholders should contact their broker or other intermediary for details.
If any holder of common shares fails to surrender to the depositary the certificates formerly representing common shares, together with such other documents required to entitle the holder to receive payment for his/her/its common shares, on or before July 6, 2015, such certificates will cease to represent a claim by or interest of any kind of a holder, and the payment to which the former holder was entitled will be deemed to have been surrendered and forfeited to IPIC for no consideration.
Investor inquiries, please contact:
Leader, External Financial Reporting
Media inquiries, please contact: